DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Therapeutic Variables in Cataract Surgery

Information source: Innovative Medical
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cataract Surgery

Intervention: Gatifloxacin (Drug); Ketorolac LS (Drug); Pred Forte (Drug); Moxifloxacin (Drug); Nepafenac (Drug); EconoPred Plus (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Innovative Medical

Official(s) and/or principal investigator(s):
William Trattler, MD, Principal Investigator, Affiliation: The Center For Excellence in Eye Care


The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

Clinical Details

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind


Minimum age: N/A. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Males or females scheduled to undergo cataract surgery

- Patients can be receiving monofocal IOLs only

- Likely to complete all study visits and able to provide informed consent

- Visual potential of 20/25 or better

Exclusion Criteria:

- Known contraindications to any study medication or ingredients

- Active ocular diseases or uncontrolled systemic disease

- Active ocular allergies

Locations and Contacts

The Center for Excellence in Eye Care, Miami, Florida 33176, United States
Additional Information

Last updated: August 17, 2007

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017